牛叉诊股

[{"date":"2026.02.26","stock":"-2.66","trade":"-0.81","ind":"0.19"},{"date":"2026.02.25","stock":"0.70","trade":"0.87","ind":"1.29"},{"date":"2026.02.24","stock":"0.26","trade":"0.55","ind":"1.36"},{"date":"2026.02.13","stock":"-1.20","trade":"-0.79","ind":"-1.28"},{"date":"2026.02.12","stock":"-1.00","trade":"-1.10","ind":"0.86"},{"date":"2026.02.11","stock":"-0.81","trade":"-0.46","ind":"-0.35"},{"date":"2026.02.10","stock":"0.25","trade":"0.52","ind":"0.02"},{"date":"2026.02.09","stock":"-0.80","trade":"0.67","ind":"2.17"},{"date":"2026.02.06","stock":"0.00","trade":"0.56","ind":"-0.33"},{"date":"2026.02.05","stock":"0.43","trade":"0.23","ind":"-1.44"},{"date":"2026.02.04","stock":"1.13","trade":"0.76","ind":"2.40"},{"date":"2026.02.02","stock":"-5.42","trade":"-2.55","ind":"-2.69"},{"date":"2026.01.30","stock":"0.24","trade":"-0.63","ind":"-0.66"},{"date":"2026.01.29","stock":"0.36","trade":"-0.82","ind":"-0.30"},{"date":"2026.01.28","stock":"-2.25","trade":"-1.60","ind":"0.09"},{"date":"2026.01.27","stock":"-0.71","trade":"-1.34","ind":"0.09"},{"date":"2026.01.26","stock":"-3.74","trade":"0.66","ind":"-0.85"},{"date":"2026.01.23","stock":"1.38","trade":"1.43","ind":"0.79"},{"date":"2026.01.22","stock":"-2.57","trade":"-0.07","ind":"0.50"},{"date":"2026.01.21","stock":"-0.56","trade":"0.37","ind":"0.70"},{"date":"2026.01.20","stock":false,"trade":null,"ind":"-0.97"}]

奥赛康,深证成指,化学制药指数

压力支撑

该股压力位为15.47元，支撑位为15.20元。

[{"text":"\u538b\u529b\u4f4d","value":"15.47","date":1772035200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.20","date":1772035200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.6资金面打败了74%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：02月26日 20:30

机构今日流向(万元)	-3278.63	机构5日流向(万元)	-6736.35
机构10日流向(万元)	-6376.25	机构20日流向(万元)	-19711.53

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少76091.1万股，其中基金数没有增加，主力净减仓198家，请投资者中长期谨慎为宜。

截止2025-12-31，共12家主力机构（基金12家），持仓量总计3667.24万股，占流通A股3.95%
其中，基金持仓与2025-06-30相比：
增仓：2家，增持 1989.39万股
减仓：2家，减持 17.46万股
新出现在主力名单中：8家，持有434.07万股
从主力名单中消失：206家，原持有78497.1万股

消息面诊股

诊断结果：5消息面打败了35%的股票今日有利好新闻的公司

近期该股消息很少，消息面信号较弱。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-09-19
一般消息	股东大会	临时股东大会	2025-08-29
一般消息	分红转增	不分配不转增	2025-08-29
利好	分红转增	10派1.2元(含税)	2025-04-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：2.6行业面打败了19%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.02.26","price":"0.19","value":"-0.81"},{"date":"2026.02.25","price":"1.29","value":"0.87"},{"date":"2026.02.24","price":"1.36","value":"0.55"},{"date":"2026.02.13","price":"-1.28","value":"-0.79"},{"date":"2026.02.12","price":"0.86","value":"-1.10"},{"date":"2026.02.11","price":"-0.35","value":"-0.46"},{"date":"2026.02.10","price":"0.02","value":"0.52"},{"date":"2026.02.09","price":"2.17","value":"0.67"},{"date":"2026.02.06","price":"-0.33","value":"0.56"},{"date":"2026.02.05","price":"-1.44","value":"0.23"},{"date":"2026.02.04","price":"2.40","value":"0.76"},{"date":"2026.02.02","price":"-2.69","value":"1.56"},{"date":"2026.01.30","price":"-0.66","value":"-2.55"},{"date":"2026.01.29","price":"-0.30","value":"-0.63"},{"date":"2026.01.28","price":"0.09","value":"-0.82"},{"date":"2026.01.27","price":"0.09","value":"-1.60"},{"date":"2026.01.26","price":"-0.85","value":"-1.34"},{"date":"2026.01.23","price":"0.79","value":"0.66"},{"date":"2026.01.22","price":"0.50","value":"1.43"},{"date":"2026.01.21","price":"0.70","value":"-0.07"},{"date":"2026.01.20","price":"-0.97","value":"0.37"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	广生堂	43.63%	-11.81%	3.9分
2	海翔药业	38.62%	7.68%	5.9分
3	科源制药	37.06%	15.32%	5.5分
4	浙江医药	15.77%	2.12%	6.2分
5	新和成	12.99%	2.00%	6.3分
6	润都股份	12.96%	-5.80%	5.0分
7	仟源医药	11.85%	6.47%	6.7分
8	北陆药业	10.22%	-2.05%	5.1分
9	海欣股份	8.42%	-2.37%	6.1分
10	ST人福	8.39%	4.27%	6.4分
11	尔康制药	8.35%	12.63%	4.8分
12	东亚药业	7.73%	6.64%	5.4分
13	赛分科技	6.63%	3.78%	6.5分
14	ST天圣	6.43%	1.15%	5.8分
15	广济药业	5.65%	-1.63%	5.9分
16	易明医药	4.81%	-0.05%	5.4分
17	本立科技	4.54%	0.90%	6.3分
18	健友股份	4.53%	-0.20%	5.5分
19	国邦医药	4.19%	-0.74%	5.9分
20	美诺华	3.68%	0.52%	5.6分
21	同和药业	3.57%	-1.98%	6.0分
22	神奇制药	3.35%	-0.31%	6.2分
23	苑东生物	3.35%	-10.52%	4.8分
24	赛托生物	3.32%	-0.47%	5.6分
25	联环药业	3.10%	-3.76%	4.7分
26	丰原药业	2.91%	0.45%	5.8分
27	能特科技	2.61%	0.00%	5.4分
28	河化股份	2.19%	1.08%	6.0分
29	川宁生物	1.81%	-0.88%	5.0分
30	亿帆医药	1.79%	6.94%	5.4分
31	中关村	1.56%	-1.33%	5.4分
32	多瑞医药	1.55%	-0.09%	5.2分
33	山河药辅	1.40%	-0.63%	6.0分
34	亨迪药业	1.18%	-0.47%	4.6分
35	金城医药	1.13%	-1.87%	5.0分
36	天新药业	0.85%	-0.18%	5.3分
37	-	0.76%	0.20%	分
38	西点药业	0.67%	-0.76%	5.5分
39	国药现代	0.66%	-1.85%	5.3分
40	仙琚制药	0.64%	0.86%	5.2分
41	罗欣药业	0.61%	-2.94%	5.7分
42	津药药业	0.47%	-1.17%	5.0分
43	华仁药业	0.31%	-0.30%	5.6分
44	海森药业	0.13%	-1.93%	4.8分
45	纳微科技	0.04%	1.52%	4.2分
46	*ST三圣	0.00%	0.46%	5.3分
47	哈药股份	-0.28%	-0.57%	5.1分
48	溢多利	-0.57%	0.14%	5.0分
49	新天地	-0.63%	-0.63%	5.1分
50	拓新药业	-0.68%	0.79%	3.5分
51	共同药业	-0.69%	-0.83%	4.9分
52	复旦张江	-0.69%	-1.59%	4.6分
53	华润双鹤	-0.70%	-1.28%	4.8分
54	鲁抗医药	-0.87%	-0.33%	4.2分
55	华特达因	-0.89%	-0.83%	5.4分
56	九典制药	-0.95%	0.26%	4.8分
57	海正药业	-0.95%	-1.70%	5.1分
58	德展健康	-1.02%	-1.78%	3.1分
59	力生制药	-1.05%	-0.23%	6.0分
60	-	-1.07%	0.40%	分
61	ST复华	-1.12%	-0.94%	4.0分
62	誉衡药业	-1.14%	0.87%	5.6分
63	丽珠集团	-1.17%	-0.25%	4.9分
64	威尔药业	-1.18%	-1.82%	5.5分
65	-	-1.19%	-1.61%	分
66	卫信康	-1.23%	-1.67%	5.3分
67	华北制药	-1.24%	-1.07%	4.6分
68	-	-1.36%	-0.46%	分
69	奥翔药业	-1.42%	-1.62%	4.0分
70	普洛药业	-1.57%	-3.04%	4.7分
71	金石亚药	-1.65%	-1.11%	4.9分
72	宏源药业	-1.83%	0.87%	5.9分
73	诚意药业	-1.86%	-2.69%	5.0分
74	东北制药	-1.89%	-0.95%	5.2分
75	华邦健康	-1.95%	1.28%	5.3分
76	海普瑞	-2.03%	-2.90%	4.7分
77	恩华药业	-2.13%	-0.04%	5.2分
78	宣泰医药	-2.17%	-0.58%	4.1分
79	-	-2.18%	1.32%	分
80	小方制药	-2.42%	-1.52%	4.3分
81	-	-2.47%	-0.43%	分
82	北大医药	-2.49%	-1.26%	4.7分
83	南新制药	-2.77%	-2.77%	4.5分
84	盟科药业	-2.79%	-1.88%	4.6分
85	福安药业	-2.84%	-0.22%	3.9分
86	莎普爱思	-2.99%	-1.19%	4.5分
87	泰恩康	-3.03%	-1.70%	4.0分
88	莱美药业	-3.24%	1.40%	4.1分
89	舒泰神	-3.24%	-2.74%	4.4分
90	复星医药	-3.25%	-2.64%	4.7分
91	吉贝尔	-3.41%	-1.14%	4.8分
92	灵康药业	-3.56%	-2.54%	4.7分
93	花园生物	-3.60%	-3.92%	4.8分
94	民生健康	-4.06%	-2.38%	4.5分
95	新华制药	-4.11%	-0.19%	4.9分
96	千红制药	-4.29%	-1.39%	4.5分
97	-	-4.38%	-0.53%	分
98	圣诺生物	-4.47%	-0.10%	5.1分
99	健康元	-4.51%	-2.31%	4.7分
100	贝达药业	-4.52%	-2.48%	4.6分
101	司太立	-4.81%	0.87%	5.2分
102	泽璟制药	-4.98%	-13.74%	3.6分
103	富祥药业	-5.19%	0.06%	4.8分
104	亚太药业	-5.20%	-2.81%	4.5分
105	汉商集团	-5.21%	3.49%	5.7分
106	金陵药业	-5.27%	-1.69%	4.9分
107	哈三联	-5.33%	-0.33%	4.7分
108	恒瑞医药	-5.62%	-3.70%	4.5分
109	翰宇药业	-5.74%	0.16%	5.2分
110	辰欣药业	-5.80%	-0.34%	4.6分
111	首药控股	-5.97%	-5.84%	4.7分
112	华海药业	-6.10%	-2.36%	4.0分
113	天宇股份	-6.23%	-4.46%	6.0分
114	华东医药	-6.25%	-2.51%	5.1分
115	昂利康	-6.26%	-1.66%	5.3分
116	富士莱	-6.27%	-0.11%	6.0分
117	艾力斯	-6.33%	-4.02%	4.3分
118	永安药业	-6.43%	-0.34%	4.3分
119	向日葵	-6.48%	-0.22%	4.2分
120	-	-6.52%	-2.27%	分
121	华纳药厂	-6.56%	-5.62%	3.7分
122	信立泰	-6.64%	-8.47%	5.5分
123	科伦药业	-6.65%	-4.90%	5.0分
124	键凯科技	-6.79%	-1.03%	5.9分
125	-	-7.03%	-0.27%	分
126	微芯生物	-7.38%	2.95%	5.1分
127	汇宇制药	-7.63%	-1.13%	4.4分
128	立方制药	-8.28%	-4.41%	5.4分
129	百利天恒	-8.86%	-5.43%	4.4分
130	海思科	-9.14%	-4.84%	5.6分
131	东诚药业	-9.15%	-1.92%	4.5分
132	海辰药业	-9.18%	3.60%	4.8分
133	一品红	-9.29%	-2.90%	4.4分
134	上海谊众	-9.30%	-6.28%	5.1分
135	百济神州	-9.93%	-8.29%	4.1分
136	福元医药	-9.96%	-7.05%	4.4分
137	康芝药业	-10.35%	0.43%	4.1分
138	海创药业	-10.37%	-3.19%	4.3分
139	兴齐眼药	-10.67%	3.37%	6.0分
140	海南海药	-10.73%	-4.92%	4.1分
141	亚虹医药	-11.17%	-1.49%	3.5分
142	博瑞医药	-12.06%	-4.92%	3.4分
143	京新药业	-12.07%	-5.03%	4.6分
144	通化金马	-12.57%	0.30%	4.7分
145	*ST赛隆	-13.12%	0.86%	4.1分
146	ST诺泰	-14.08%	-7.08%	4.4分
147	奥赛康	-14.21%	-3.88%	4.5分
148	常山药业	-14.57%	2.01%	4.0分
149	*ST景峰	-14.77%	0.15%	4.9分
150	奥锐特	-14.86%	-1.60%	4.7分
151	双鹭药业	-14.91%	-1.98%	3.8分
152	新诺威	-15.04%	-5.92%	4.4分
153	前沿生物	-16.73%	-5.99%	4.1分
154	迪哲医药	-18.58%	-8.03%	4.0分
155	必贝特	-24.87%	-7.62%	4.5分
156	益方生物	-25.03%	-9.19%	3.6分
157	悦康药业	-26.54%	-6.19%	3.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.4基本面打败了73%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值一般。

个股深一度

潜在高分红能力：弱（37.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 41/218 ， 20/218。

[{"date":"2025-09-30","value":"7.13","vol":"1.51"},{"date":"2025-06-30","value":"5.16","vol":"1.23"},{"date":"2025-03-31","value":"1.76","vol":"-0.14"},{"date":"2024-12-31","value":"5.38","vol":"19.62"},{"date":"2024-09-30","value":"4.31","vol":"4.62"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	7.13	5.16	1.76	5.38	4.31
行业(%)	1.51	1.23	-0.14	19.62	4.62

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"79.80","vol":"49.36"},{"date":"2025-06-30","value":"81.69","vol":"49.33"},{"date":"2025-03-31","value":"82.50","vol":"49.14"},{"date":"2024-12-31","value":"81.34","vol":"50.78"},{"date":"2024-09-30","value":"81.83","vol":"50.61"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	79.80	81.69	82.50	81.34	81.83
行业(%)	49.36	49.33	49.14	50.78	50.61

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 45/218 ， 20/218。

[{"date":"2025-09-30","value":"3.57","vol":"142.98"},{"date":"2025-06-30","value":"9.20","vol":"79.25"},{"date":"2025-03-31","value":"13.39","vol":"-0.67"},{"date":"2024-12-31","value":"23.15","vol":"18.07"},{"date":"2024-09-30","value":"23.64","vol":"45.94"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	3.57	9.20	13.39	23.15	23.64
行业(%)	142.98	79.25	-0.67	18.07	45.94

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"75.81","vol":"-3.26"},{"date":"2025-06-30","value":"111.64","vol":"58.57"},{"date":"2025-03-31","value":"73.50","vol":"-11.22"},{"date":"2024-12-31","value":"207.92","vol":"-22.02"},{"date":"2024-09-30","value":"168.79","vol":"-34.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	75.81	111.64	73.50	207.92	168.79
行业(%)	-3.26	58.57	-11.22	-22.02	-34.66

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/218 ， 63/218。

[{"date":"2025-09-30","value":"0.34","vol":"0.31"},{"date":"2025-06-30","value":"0.24","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.47","vol":"0.43"},{"date":"2024-09-30","value":"0.37","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.34	0.24	0.12	0.47	0.37
行业(次)	0.31	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.79","vol":"1.94"},{"date":"2025-06-30","value":"1.06","vol":"1.30"},{"date":"2025-03-31","value":"0.46","vol":"0.66"},{"date":"2024-12-31","value":"1.82","vol":"3.19"},{"date":"2024-09-30","value":"1.42","vol":"2.12"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.79	1.06	0.46	1.82	1.42
行业(次)	1.94	1.30	0.66	3.19	2.12

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"41.95","vol":"4.43"},{"date":"2025-06-30","value":"46.99","vol":"2.74"},{"date":"2025-03-31","value":"37.06","vol":"-26.98"},{"date":"2024-12-31","value":"-9.20","vol":"-373.99"},{"date":"2024-09-30","value":"32.65","vol":"-9.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	41.95	46.99	37.06	-9.20	32.65
行业	4.43	2.74	-26.98	-373.99	-9.47

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.97","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.50","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.97	-	2.50	-
行业	0.00	1.73	0.00	2.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 55/218 ， 102/218。

[{"date":"2025-09-30","value":"2.72","vol":"3.50"},{"date":"2025-06-30","value":"2.57","vol":"3.69"},{"date":"2025-03-31","value":"2.95","vol":"3.61"},{"date":"2024-12-31","value":"3.13","vol":"3.36"},{"date":"2024-09-30","value":"3.41","vol":"3.67"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.72	2.57	2.95	3.13	3.41
行业	3.50	3.69	3.61	3.36	3.67

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.56","vol":"2.75"},{"date":"2025-06-30","value":"2.41","vol":"2.90"},{"date":"2025-03-31","value":"2.73","vol":"2.83"},{"date":"2024-12-31","value":"2.85","vol":"2.65"},{"date":"2024-09-30","value":"3.13","vol":"2.93"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	2.56	2.41	2.73	2.85	3.13
行业	2.75	2.90	2.83	2.65	2.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 82/218 ， 86/218。

[{"date":"2025-09-30","value":"26.25","vol":"33.63"},{"date":"2025-06-30","value":"27.19","vol":"33.66"},{"date":"2025-03-31","value":"24.09","vol":"33.90"},{"date":"2024-12-31","value":"22.37","vol":"34.07"},{"date":"2024-09-30","value":"20.97","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	26.25	27.19	24.09	22.37	20.97
行业(%)	33.63	33.66	33.90	34.07	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.36","vol":"0.94"},{"date":"2025-06-30","value":"0.38","vol":"0.88"},{"date":"2025-03-31","value":"0.33","vol":"1.47"},{"date":"2024-12-31","value":"0.30","vol":"0.84"},{"date":"2024-09-30","value":"0.28","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.36	0.38	0.33	0.30	0.28
行业(%)	0.94	0.88	1.47	0.84	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.80","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-2.26","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.60","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.63","blueLineValue":"0.28","type":"YC"}]

[奥赛康]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]